{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:13:53Z","timestamp":1785413633023,"version":"3.56.0"},"reference-count":52,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["ATIP"],"award-info":[{"award-number":["ATIP"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["Region Midi Pyrenees - Equipe d'excellence"],"award-info":[{"award-number":["Region Midi Pyrenees - Equipe d'excellence"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["Region Midi Pyrenees - FEDER"],"award-info":[{"award-number":["Region Midi Pyrenees - FEDER"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation InnaBioSante","award":["EpAM"],"award-info":[{"award-number":["EpAM"]}]},{"DOI":"10.13039\/100005984","name":"Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,9,18]]},"abstract":"<jats:p>Aberrant DNA methylation is a well-known feature of tumours and has been associated with metastatic melanoma. However, since melanoma cells are highly heterogeneous, it has been challenging to use affected genes to predict tumour aggressiveness, metastatic evolution, and patients\u2019 outcomes. We hypothesized that common aggressive hypermethylation signatures should emerge early in tumorigenesis and should be shared in aggressive cells, independent of the physiological context under which this trait arises. We compared paired melanoma cell lines with the following properties: (i) each pair comprises one aggressive counterpart and its parental cell line and (ii) the aggressive cell lines were each obtained from different host and their environment (human, rat, and mouse), though starting from the same parent cell line. Next, we developed a multi-step genomic pipeline that combines the DNA methylome profile with a chromosome cluster-oriented analysis. A total of 229 differentially hypermethylated genes was commonly found in the aggressive cell lines. Genome localization analysis revealed hypermethylation peaks and clusters, identifying eight hypermethylated gene promoters for validation in tissues from melanoma patients. Five Cytosine-phosphate-Guanine (CpGs) identified in primary melanoma tissues were transformed into a DNA methylation score that can predict survival (log-rank test, p=0.0008). This strategy is potentially universally applicable to other diseases involving DNA methylation alterations.<\/jats:p>","DOI":"10.7554\/elife.78587","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T08:02:28Z","timestamp":1663660948000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.78587","source":"Crossref","is-referenced-by-count":5,"title":["DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness"],"prefix":"10.7554","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-7685","authenticated-orcid":true,"given":"Arnaud","family":"Carrier","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02feahw73","id-type":"ROR","asserted-by":"publisher"}],"name":"Unit\u00e9 de Service et de Recherche USR 3388, CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC)","place":["Toulouse, France"]},{"id":[{"id":"https:\/\/ror.org\/00btzwk36","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Epigenetics Group, Josep Carreras Leukemia Research Institute (IJC)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Desjobert","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02feahw73","id-type":"ROR","asserted-by":"publisher"}],"name":"Unit\u00e9 de Service et de Recherche USR 3388, CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC)","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Ponger","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02feahw73","id-type":"ROR","asserted-by":"publisher"}],"name":"CNRS UMR 7196, INSERM U1154, Sorbone university- National museum of natural history (NMNH)","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/003412r28","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Research Center of Toulouse, UMR 1037, INSERM, Universit\u00e9 Toulouse III Paul Sabatier","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Bustos","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01gcc9p15","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Translational Molecular Medicine, Saint John\u2019s Cancer Institute, Providence Saint John's Health Center","place":["Santa Monica, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Torres-Ferreira","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00r7b5b77","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Biology and Epigenetics Group, Research Center (CI-IPOP)\/P.CCC Porto Comprehensive Cancer Center, Portuguese Oncology Institute of Porto (IPO Porto)","place":["Porto, Portugal"]},{"id":[{"id":"https:\/\/ror.org\/00r7b5b77","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)\/P.CCC Porto Comprehensive Cancer Center","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00r7b5b77","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Biology and Epigenetics Group, Research Center (CI-IPOP)\/P.CCC Porto Comprehensive Cancer Center, Portuguese Oncology Institute of Porto (IPO Porto)","place":["Porto, Portugal"]},{"id":[{"id":"https:\/\/ror.org\/00r7b5b77","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)\/P.CCC Porto Comprehensive Cancer Center","place":["Porto, Portugal"]},{"id":[{"id":"https:\/\/ror.org\/043pwc612","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology and Molecular Immunology, Biomedical Sciences Institute (ICBAS), University of Porto","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Jeronimo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00r7b5b77","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Biology and Epigenetics Group, Research Center (CI-IPOP)\/P.CCC Porto Comprehensive Cancer Center, Portuguese Oncology Institute of Porto (IPO Porto)","place":["Porto, Portugal"]},{"id":[{"id":"https:\/\/ror.org\/00r7b5b77","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)\/P.CCC Porto Comprehensive Cancer Center","place":["Porto, Portugal"]},{"id":[{"id":"https:\/\/ror.org\/043pwc612","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology and Molecular Immunology, Biomedical Sciences Institute (ICBAS), University of Porto","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Lanfrancone","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vr0ne26","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Experimental Oncology, Instituto Europeo di Oncologia","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Delmas","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/003412r28","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Research Center of Toulouse, UMR 1037, INSERM, Universit\u00e9 Toulouse III Paul Sabatier","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Favre","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/003412r28","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Research Center of Toulouse, UMR 1037, INSERM, Universit\u00e9 Toulouse III Paul Sabatier","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Daunay","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01rje3r53","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory for Functional Genomics, Fondation Jean Dausset-CEPH","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Busato","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/004yvsb77","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory for Epigenetics and Environment, Centre National de Recherche en G\u00e9nomique Humaine, CEA-Institut de Biologie Fran\u00e7ois Jacob","place":["Evry, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave SB","family":"Hoon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01gcc9p15","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Translational Molecular Medicine, Saint John\u2019s Cancer Institute, Providence Saint John's Health Center","place":["Santa Monica, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorg","family":"Tost","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/004yvsb77","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory for Epigenetics and Environment, Centre National de Recherche en G\u00e9nomique Humaine, CEA-Institut de Biologie Fran\u00e7ois Jacob","place":["Evry, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Etievant","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02feahw73","id-type":"ROR","asserted-by":"publisher"}],"name":"Unit\u00e9 de Service et de Recherche USR 3388, CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC)","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6281-2376","authenticated-orcid":true,"given":"Jo\u00eblle","family":"Riond","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02feahw73","id-type":"ROR","asserted-by":"publisher"}],"name":"Unit\u00e9 de Service et de Recherche USR 3388, CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC)","place":["Toulouse, France"]},{"id":[{"id":"https:\/\/ror.org\/003412r28","id-type":"ROR","asserted-by":"publisher"}],"name":"Cancer Research Center of Toulouse, UMR 1037, INSERM, Universit\u00e9 Toulouse III Paul Sabatier","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-4396","authenticated-orcid":true,"given":"Paola B","family":"Arimondo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02feahw73","id-type":"ROR","asserted-by":"publisher"}],"name":"Unit\u00e9 de Service et de Recherche USR 3388, CNRS-Pierre Fabre, Epigenetic Targeting of Cancer (ETaC)","place":["Toulouse, France"]},{"id":[{"id":"https:\/\/ror.org\/02feahw73","id-type":"ROR","asserted-by":"publisher"}],"name":"EpiCBio, Epigenetic Chemical Biology, Department Structural Biology and Chemistry, Institut Pasteur, CNRS UMR 3523","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1158\/0008-5472.828.65.3","article-title":"Cpg island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas","volume":"65","author":"Abe","year":"2005","journal-title":"Cancer Research"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/ijc.2910490520","article-title":"Human tumor spontaneous metastasis in immunosuppressed newborn rats. II. multiple selections of human melanoma metastatic clones and variants","volume":"49","author":"Bailly","year":"1991","journal-title":"International Journal of Cancer"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/labinvest.2011.169","article-title":"A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype","volume":"92","author":"Banelli","year":"2012","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-genet-110410-132459","article-title":"Genomic imprinting: a mammalian epigenetic discovery model","volume":"45","author":"Barlow","year":"2011","journal-title":"Annual Review of Genetics"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"R965","DOI":"10.1186\/bcr1329","article-title":"Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells","volume":"7","author":"Baugher","year":"2005","journal-title":"Breast Cancer Research"},{"key":"bib6","first-page":"3441","article-title":"Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers","volume":"27","author":"Bertucci","year":"2007","journal-title":"Anticancer Research"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52134-4","article-title":"Prediction and analysis of skin cancer progression using genomics profiles of patients","volume":"9","author":"Bhalla","year":"2019","journal-title":"Scientific Reports"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.1038\/sj.onc.1208909","article-title":"Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion","volume":"24","author":"Chan","year":"2005","journal-title":"Oncogene"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.18632\/oncotarget.14042","article-title":"Genome-Wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for Ebf3 as a candidate epigenetic driver of melanoma metastasis","volume":"8","author":"Chatterjee","year":"2017","journal-title":"Oncotarget"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/35020106","article-title":"Genomic analysis of metastasis reveals an essential role for RhoC","volume":"406","author":"Clark","year":"2000","journal-title":"Nature"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ncb2023","article-title":"Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity","volume":"12","author":"Coolen","year":"2010","journal-title":"Nature Cell Biology"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0600-2","article-title":"Demethylation by low-dose 5-Aza-2 \u2019 -deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma","volume":"11","author":"Desjobert","year":"2019","journal-title":"Clinical Epigenetics"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/bjd.16254","article-title":"Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma","volume":"179","author":"de Unamuno Bustos","year":"2018","journal-title":"The British Journal of Dermatology"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","article-title":"Regulation of the MIR155 host gene in physiological and pathological processes","volume":"532","author":"Elton","year":"2013","journal-title":"Gene"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.it.2019.02.004","article-title":"Targeting DNA methylation and EZH2 activity to overcome melanoma resistance to immunotherapy","volume":"40","author":"Emran","year":"2019","journal-title":"Trends in Immunology"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nature Reviews. Genetics"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jama.2015.10414","article-title":"Epigenetics at the crossroads of genes and the environment","volume":"314","author":"Feinberg","year":"2015","journal-title":"JAMA"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ng1781","article-title":"Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band","volume":"38","author":"Frigola","year":"2006","journal-title":"Nature Genetics"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/pcmr.12096","article-title":"Genome-Wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma","volume":"26","author":"Gao","year":"2013","journal-title":"Pigment Cell & Melanoma Research"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American joint Committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.44310","article-title":"A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma","volume":"8","author":"Guo","year":"2019","journal-title":"eLife"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF00205410","article-title":"Tumour-Associated antigens in culture medium of malignant melanoma cell strains","volume":"7","author":"Jacubovich","year":"1979","journal-title":"Cancer Immunology Immunotherapy"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/JTO.0b013e318220ef9a","article-title":"Shox2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma","volume":"6","author":"Kneip","year":"2011","journal-title":"Journal of Thoracic Oncology"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/ijo_00000352","article-title":"Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of mirna-155","volume":"35","author":"Levati","year":"2009","journal-title":"International Journal of Oncology"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000090818","article-title":"How imprinting centres work","volume":"113","author":"Lewis","year":"2006","journal-title":"Cytogenetic and Genome Research"},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.1038\/srep02962","article-title":"Genome-Wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network","volume":"3","author":"Li","year":"2013","journal-title":"Scientific Reports"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1007\/s13277-014-1905-1","article-title":"Aberrant promoter methylation of the vimentin gene may contribute to colorectal carcinogenesis: a meta-analysis","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biology"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1042\/bj3200473","article-title":"Spreading of methylation along DNA","volume":"320 (Pt 2)","author":"Lindsay","year":"1996","journal-title":"The Biochemical Journal"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2022.03.002","article-title":"Osteosarcoma: novel prognostic biomarkers using circulating and cell-free tumour DNA","volume":"168","author":"Lyskj\u00e6r","year":"2022","journal-title":"European Journal of Cancer"},{"key":"bib32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012334","article-title":"Identification of methylated genes associated with aggressive bladder cancer","volume":"5","author":"Marsit","year":"2010","journal-title":"PLOS ONE"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/hmg\/ddt420","article-title":"Epigenome-Wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis","volume":"23","author":"Marzese","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2217\/epi.15.77","article-title":"Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives","volume":"7","author":"Marzese","year":"2015","journal-title":"Epigenomics"},{"key":"bib35","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0332-8","article-title":"Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities","volume":"9","author":"Micevic","year":"2017","journal-title":"Clinical Epigenetics"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41580-019-0143-1","article-title":"The roles of DNA, RNA and histone methylation in ageing and cancer","volume":"20","author":"Michalak","year":"2019","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/or_00000814","article-title":"Bcl2L10 is frequently silenced by promoter hypermethylation in gastric cancer","volume":"23","author":"Mikata","year":"2010","journal-title":"Oncology Reports"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2017.10.006","article-title":"Epigenetics of malignant melanoma","volume":"51","author":"Moran","year":"2018","journal-title":"Seminars in Cancer Biology"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2217\/epi.10.35","article-title":"From discovery to the clinic: the novel DNA methylation biomarker (M) SEPT9 for the detection of colorectal cancer in blood","volume":"2","author":"Payne","year":"2010","journal-title":"Epigenomics"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054958","article-title":"Integrative genomics identifies gene signature associated with melanoma ulceration","volume":"8","author":"Rakosy","year":"2013","journal-title":"PLOS ONE"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-185","article-title":"Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients","volume":"10","author":"Sigalotti","year":"2012","journal-title":"Journal of Translational Medicine"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1158\/1078-0432.CCR-08-1361","article-title":"Cpg island methylator phenotype predicts progression of malignant melanoma","volume":"15","author":"Tanemura","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"bib43","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-019-1669-6","article-title":"Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage","volume":"17","author":"Teterycz","year":"2019","journal-title":"World Journal of Surgical Oncology"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0304-3835(94)03624-r","article-title":"Correlation between the radiosensitivity in vitro of clones and variants derived from a human melanoma cell line and their spontaneous metastatic potential in vivo","volume":"88","author":"Thomas","year":"1995","journal-title":"Cancer Letters"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/15592294.2016.1216284","article-title":"Methylation status of the SOCS3 gene in human malignant melanomas","volume":"30","author":"Tokita","year":"2007","journal-title":"International Journal of Oncology"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/nprot.2007.314","article-title":"Dna methylation analysis by pyrosequencing","volume":"2","author":"Tost","year":"2007","journal-title":"Nature Protocols"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/epi.12.21","article-title":"Complete pipeline for infinium human methylation 450K beadchip data processing using subset quantile normalization for accurate DNA methylation estimation","volume":"4","author":"Touleimat","year":"2012","journal-title":"Epigenomics"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-06-1670","article-title":"A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma","volume":"13","author":"Vachani","year":"2007","journal-title":"Clinical Cancer Research"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/leu.2011.170","article-title":"Role of Bcl2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine","volume":"25","author":"Voso","year":"2011","journal-title":"Leukemia"},{"key":"bib50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051081","article-title":"Downregulation of the ubiquitin-E3 ligase RNF123 promotes upregulation of the NF-\u03baB1 target SerpinE1 in aggressive glioblastoma tumors","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of melanoma: facts and hopes","volume":"25","author":"Weiss","year":"2019","journal-title":"Clinical Cancer Research"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/path.2811","article-title":"Bcl2L10 protein regulates apoptosis\/proliferation through differential pathways in gastric cancer cells","volume":"223","author":"Xu","year":"2011","journal-title":"The Journal of Pathology"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/78587\/elife-78587-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/78587\/elife-78587-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/78587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:21:15Z","timestamp":1697059275000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/78587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":52,"alternative-id":["10.7554\/eLife.78587"],"URL":"https:\/\/doi.org\/10.7554\/elife.78587","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.11.487909","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.04.11.487909","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"accession","id":"GSE155856","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.78587.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.78587.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.78587.sa2","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e78587"}}